APR Applied Pharma Research granted FDA orphan drug designation for APR-OD031 for treating PKU

Inovio Reports Positive Interim Phase 2 VGX-3100 Results in Patients with HPV-associated Anal Dysplasia

Decibel Therapeutics Publishes Results from Early-Stage Study of Therapy Designed to Prevent Hearing Loss Associated with Cisplatin Chemotherapy

US Food and Drug Administration Approves Bristol Myers Squibb's Zeposia for Relapsing Forms of Multiple Sclerosis

AgNovos Healthcare Receives Breakthrough Designation for Spine Device

Quidel's Lyra SARS-CoV-2 Assay Receives Authorisation from US FDA for Expanded Use for Molecular Detection of COVID-19

Forge Therapeutics signs research collaboration and option agreement with Hoffmann-La Roche

Exelixis Partner Takeda Receives Approval in Japan for Cabometyx Tablets for the Treatment of Curatively Unresectable or Metastatic Renal Cell Carcinoma

Bruker Launches CE-IVD Marked Genesig Assay Kit for the Detection of the SARS-CoV-2 Virus

Alnylam Pharmaceuticals, Gen Sign Distribution Agreement in Turkey for Onpattro 'Gene-Silencing' RNAi Therapeutic

Stemcell Technologies Provides Support to Sequence the COVID-19 Virus, Accelerating Vaccine Development

Nuclein to Expedite Commercialisation of Hand-Held PCR Test to Aid in COVID-19 Pandemic

Crescita Therapeutics to take measures in response to COVID-19

Partner Therapeutics to assess Leukine in SARPAC trial for COVID-19 Associated Respiratory Illness

Partner Therapeutics to evaluate Leukine in SARPAC trial to treat patients with respiratory illness associated with COVID-19